ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) insider Christopher Mutz sold 3,162 shares of the business’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $71.64, for a total value of $226,525.68. Following the completion of the sale, the insider owned 91,309 shares in the company, […]

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) insider Krishnan Viswanadhan sold 2,959 shares of the stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $27.80, for a total transaction of $82,260.20. Following the completion of the sale, the insider directly owned 5,141 shares of the company’s […]

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) EVP Christine Fox sold 7,924 shares of the business’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $31.67, for a total transaction of $250,953.08. Following the sale, the executive vice president directly owned 84,905 shares of the […]

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) CEO Richard Francis sold 20,025 shares of the company’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $31.67, for a total value of $634,191.75. Following the completion of the sale, the chief executive officer owned 1,170,639 shares […]

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) General Counsel Shannon Kelley sold 360 shares of the business’s stock in a transaction dated Friday, March 6th. The shares were sold at an average price of $431.94, for a total value of $155,498.40. Following the completion of the transaction, the general counsel owned 12,138 shares in […]

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) CEO William John Sibold sold 1,663 shares of Madrigal Pharmaceuticals stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $431.94, for a total value of $718,316.22. Following the transaction, the chief executive officer owned 161,829 shares of the company’s […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Shannon Devers sold 20,106 shares of the stock in a transaction that occurred on Tuesday, March 3rd. The shares were sold at an average price of $79.40, for a total value of $1,596,416.40. Following the transaction, the executive vice president directly owned 22,541 shares of the […]

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) EVP Jeffrey Poulton sold 2,206 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $327.65, for a total value of $722,795.90. Following the transaction, the executive vice president directly owned 64,273 shares in the company, […]

Progyny, Inc. (NASDAQ:PGNY – Get Free Report) EVP Allison Swartz sold 4,657 shares of Progyny stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $17.40, for a total transaction of $81,031.80. Following the completion of the transaction, the executive vice president directly owned 89,879 shares of the […]

Akamai Technologies, Inc. (NASDAQ:AKAM – Get Free Report) EVP Mani Sundaram sold 8,642 shares of the firm’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $101.25, for a total transaction of $875,002.50. Following the completion of the transaction, the executive vice president directly owned 19,923 shares […]